Conning Inc. raised its holdings in Danaher Co. (NYSE:DHR - Free Report) by 14.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,277 shares of the conglomerate's stock after buying an additional 3,018 shares during the period. Conning Inc.'s holdings in Danaher were worth $5,573,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher during the fourth quarter worth approximately $31,000. Strategic Financial Concepts LLC bought a new position in shares of Danaher during the fourth quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher during the fourth quarter worth approximately $31,000. Finally, Teachers Insurance & Annuity Association of America bought a new position in shares of Danaher during the third quarter worth approximately $39,000. Institutional investors own 79.05% of the company's stock.
Analyst Ratings Changes
DHR has been the topic of a number of recent research reports. Robert W. Baird lowered their target price on Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Raymond James reiterated a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Barclays lowered their target price on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Jefferies Financial Group reduced their price target on Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Finally, Stifel Nicolaus increased their price target on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a research report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and a consensus target price of $278.00.
View Our Latest Research Report on Danaher
Danaher Price Performance
DHR stock traded up $0.60 during midday trading on Wednesday, reaching $202.22. 7,207,744 shares of the stock were exchanged, compared to its average volume of 4,373,626. The stock has a market capitalization of $146.06 billion, a PE ratio of 38.30, a P/E/G ratio of 2.68 and a beta of 0.83. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a fifty day moving average price of $231.17 and a 200 day moving average price of $250.62.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 EPS. As a group, analysts expect that Danaher Co. will post 7.67 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. Danaher's dividend payout ratio is currently 20.45%.
Insider Buying and Selling
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by corporate insiders.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
